04:28 PM EDT, 03/24/2026 (MT Newswires) -- Jonathan Allan, General Counsel and Corporate Secretary, on March 20, 2026, sold 9,293 shares in Stoke Therapeutics ( STOK ) for $313,038. Following the Form 4 filing with the SEC, Allan has control over a total of 19,543 common shares of the company, with 19,543 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1623526/000196671626000008/xslF345X05/form4-03242026_080316.xml